Notably, deficiency in glucosylceramidase beta 1 (GBA1) and cyclin G associated kinase (GAK) are established as genetic risk factors in 5–10% of cases of PD (Latourelle et al., 2009; Tysnes and Storstein, 2017; Avenali et al., 2020; Miyazaki et al., 2021). Here, GBA1 is linked to Parkinson disease.